by a generous bequest of Virginia
P. Engalitcheff to the Arthritis
Foundation, Maryland Chapter, the Engalitcheff
Arthritis Outcomes Initiative supports research to improve arthritis
patient outcomes, initially focused on issues related to the use
of newer approved biological agents since their long term safety
and efficacy are not yet well understood. The goal of the Engalitcheff
Arthritis Outcomes Initiative is to improve the rational use of
therapeutics and research through research and education activities
that are in the public interest but would not otherwise be done.
The purpose of this site is to make the most recent research information
from the Engalitcheff Arthritis Outcomes Initiative available to
arthritis patients and their families.
is conducted in collaboration with the University of Alabama School
of Medicine Center
for Education and Research in Therapeutics (CERTs) in musculoskeletal
diseases supported by the Agency
for Healthcare Research and Quality and the Food
and Drug Administration.